Jan 7, 2025 · Cisplatine (mylan) is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells.

Myelosuppression: cisplatin for injection can cause severe myelosuppression with fatalities due to infections. Monitor blood counts and interrupt therapy accordingly. (5.4) Advanced bladder...

Dec 18, 2018 · Cisplatin is a platinum-based alkylating agent. It is labeled for use as a single agent for the treatment of advanced transitional cell bladder cancer, and in combination with other antineoplastic agents for the treatment of metastatic testicular cancer …

pr cisplatin injection mylan std. 100 mg/100 ml (1 mg / ml) therapeutic classification antineoplastic agent caution cisplatin injection is a potent drug and should be used only by physicians experienced with cancer chemotherapeutic drugs (see …

Cisplatin Injection is a sterile, isotonic, preservative free solution containing cisplatin 1 mg/mL. For the full list of excipients, see Section 6.1 List of excipients. 3. PHARMACEUTICAL FORM. Solution for injection. 4. CLINICAL PARTICULARS. Refractory squamous cell carcinoma of the head and neck. A variety of doses and schedules are used.

Cisplatin Injection is a clear, colorless to pale yellow, sterile aqueous solution. Each 50 mL or 100 mL amber vial of Cisplatin Injection contains: 1 mg/mL cisplatin, 9 mg/mL sodium chloride, hydrochloric acid and/or sodium hydroxide to adjust pH, and water for injection to a final volume of 50 mL or 100 mL, respectively.

What is Cisplatine Mylan, concentrate for solution for infusion and when should this medicinal product be used? This medicinal product is presented as a concentrate for solution for infusion in vial. Box of 1 vial of 10ml.

What is it used for? Cisplatin can destroy cells in your body that may cause certain types of cancer (tumor of testis, tumor of ovary, tumor of the bladder, head and neck epithelial tumor, lung cancer and for cervical cancer in combination with radiotherapy). Your doctor will be able to provide you with more information. 2.

DBL Cisplatin Injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck.

Myelosuppression: cisplatin for injection can cause severe myelosuppression with fatalities due to infections. Monitor blood counts and interrupt therapy accordingly. (5.4) Advanced bladder...